More Transparent Record News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Catalyst Pharmaceuticals, Inc.’s and KYE Pharmaceuticals’ Lawsuit in Canadian Federal Court Quashes the Notice of Compliance (NOC) for Ruzurgi®
June 03, 2021 13:20 ET
| Source:
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc.
- Without an NOC, Ruzurgi
is without a Marketing Authorization in Canada
- Matter Remanded Back to Health Canada to Provide a More Transparent Record of Its Decision in Light of Firdapse
®
’s Data Protection
CORAL GABLES, Fla., June 03, 2021 (GLOBE NEWSWIRE) Catalyst Pharmaceuticals, Inc. ( Catalyst ) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, and KYE Pharmaceuticals Inc. ( KYE ), a private company headquartered in Mississauga, Ontario and focused on bringing medicines that fulfill clinically significant unmet ....

United States , Douglas Reynolds , Patrickj Mcenany , Health Canada On , Catalyst Pharmaceuticals , Canadian Federal Court , Us Food Drug Administration , Catalyst Pharmaceuticals Inc , Pharmaceuticals Inc , Health Canada , Marketing Authorization , Remanded Back , More Transparent Record , Its Decision , New Drug Submission , Jacobus Pharmaceutical , Innovative Drug , Chief Executive Officer , New Drug Application , Drug Administration , Orphan Drug Designation , Nasdaq Cprx , Catalyst Pharmaceuticals , ஒன்றுபட்டது மாநிலங்களில் , டக்ளஸ் ரெனால்ட்ஸ் , ஆரோக்கியம் கனடா ஆன் ,